Article Versions Notes

Ono M, Burgess DE, Schroder EA, Elayi CS, Anderson CL, January CT, Sun B, Immadisetty K, Kekenes-Huskey PM, Delisle BP. Long QT Syndrome Type 2: Emerging Strategies for Correcting Class 2 KCNH2 (hERG) Mutations and Identifying New Patients. Biomolecules. 2020; 10(8):1144. https://doi.org/10.3390/biom10081144

Ono, Makoto, Don E. Burgess, Elizabeth A. Schroder, Claude S. Elayi, Corey L. Anderson, Craig T. January, Bin Sun, Kalyan Immadisetty, Peter M. Kekenes-Huskey, and Brian P. Delisle. 2020. "Long QT Syndrome Type 2: Emerging Strategies for Correcting Class 2 KCNH2 (hERG) Mutations and Identifying New Patients" Biomolecules 10, no. 8: 1144. https://doi.org/10.3390/biom10081144

Ono, M., Burgess, D. E., Schroder, E. A., Elayi, C. S., Anderson, C. L., January, C. T., Sun, B., Immadisetty, K., Kekenes-Huskey, P. M., & Delisle, B. P. (2020). Long QT Syndrome Type 2: Emerging Strategies for Correcting Class 2 KCNH2 (hERG) Mutations and Identifying New Patients. Biomolecules, 10(8), 1144. https://doi.org/10.3390/biom10081144